Profile
Guillaume Descottes worked as a Director at Creadev SASU from 2010 to 2014 and as a Chargé d'Affaires at Weinberg Capital Partners SAS from 2009 to 2010.
Former positions of Guillaume Descottes
| Companies | Position | End |
|---|---|---|
Creadev SASU
 Creadev SASU Investment ManagersFinance CREADEV SAS (CREADEV) is an independent French capital investment firm which was founded in 2002. Headquartered in Paris, CREADEV is the investment holding of the Mulliez Family. The firm works autonomously, investing in innovative French companies across business sectors which harness emerging megatrends in today's society. CREADEV donates their business management expertise to the 'A chacun son Everest' Association, which helps children in remission from cancer. | Private Equity Analyst | 2014-03-31 |
Weinberg Capital Partners SAS
 Weinberg Capital Partners SAS Investment ManagersFinance Weinberg Capital Partners SAS (WCP) is a private equity firm founded in 2005 by Serge Weinberg and Philippe Klocanas. The firm is headquartered in Paris, France. | Private Equity Analyst | 2010-04-30 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Weinberg Capital Partners SAS
Weinberg Capital Partners SAS Investment ManagersFinance Weinberg Capital Partners SAS (WCP) is a private equity firm founded in 2005 by Serge Weinberg and Philippe Klocanas. The firm is headquartered in Paris, France. | Finance |
Creadev SASU
Creadev SASU Investment ManagersFinance CREADEV SAS (CREADEV) is an independent French capital investment firm which was founded in 2002. Headquartered in Paris, CREADEV is the investment holding of the Mulliez Family. The firm works autonomously, investing in innovative French companies across business sectors which harness emerging megatrends in today's society. CREADEV donates their business management expertise to the 'A chacun son Everest' Association, which helps children in remission from cancer. | Finance |
- Stock Market
- Insiders
- Guillaume Descottes